-
Recce Pharmaceuticals reports positive phase 2 data for skin infection drug
Source: Pharmafile Published on 2025-02-17
-
PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study
Source: Pharmafile Published on 2025-02-14
-
Cardinal Health’s Kangaroo OMNI™ Enteral Feeding Pump to launch in new international markets in 2025
Source: Pharmafile Published on 2025-02-06
-
European Commission launches new Biotech and Biomanufacturing Hub
Source: Pharmafile Published on 2025-02-03
-
FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors
Source: Pharmafile Published on 2025-02-03
-
Prenatal care could be revolutionised suggests studies from BrightHeart
Source: Pharmafile Published on 2025-01-31
-
CANDOR Bioscience acquired by Medix Biochemica
Source: Pharmafile Published on 2025-01-31
-
MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients
Source: Pharmafile Published on 2025-01-30
-
Bayer UK Launches New CanesMeno® Educational Hub and Product Range to Transform Menopause Support
Source: Pharmafile Published on 2025-01-30
-
NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera
Source: Pharmafile Published on 2025-01-29
-
Positive topline results announced in phase 2 Alcohol Use Disorder study
Source: Pharmafile Published on 2025-01-29
-
Results from Novadip phase 1b/2a trial reveal 88% efficacy
Source: Pharmafile Published on 2025-01-28
-
Jérôme Berger announced as strategy and finance executive at Vect-Horus
Source: Pharmafile Published on 2025-01-28
-
Research collaboration announced between Oxford University and GSK
Source: Pharmafile Published on 2025-01-27
-
Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery
Source: Pharmafile Published on 2025-01-23